Literature DB >> 14960530

Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding.

D Tripathi1, H F Lui, A Helmy, K Dabos, E Forrest, A J Stanley, R Jalan, D N Redhead, P C Hayes.   

Abstract

BACKGROUND/AIMS: Transjugular intrahepatic portosystemic stent shunt (TIPSS) is effective in the prevention of variceal rebleeding but requires invasive portographic follow up. This randomised controlled trial aims to test the hypothesis that combining variceal band ligation (VBL) with TIPSS can obviate the need for long term TIPSS surveillance without compromising clinical efficacy, and can reduce the incidence of hepatic encephalopathy. PATIENTS/
METHODS: Patients who required TIPSS for the prevention of oesophageal variceal rebleeding were randomised to either TIPSS alone (n = 39, group 1) or TIPSS plus VBL (n = 40, group 2). In group 1, patients underwent long term TIPSS angiographic surveillance. In group 2, patients entered a banding programme with TIPSS surveillance only continued for up to one year.
RESULTS: There was a tendency to higher variceal rebleeding in group 2 although this did not reach statistical significance (8% v 15%; relative hazard 0.58; 95% confidence interval (CI) 0.15-2.33; p = 0.440). Mortality (47% v 40%; relative hazard 1.31; 95% CI 0.66-2.61; p = 0.434) was similar in the two groups. Hepatic encephalopathy was significantly less in group 2 (20% v 39%; relative hazard 2.63; 95% CI 1.11-6.25; p = 0.023). Hepatic encephalopathy was not statistically different after correcting for sex and portal pressure gradient (p = 0.136).
CONCLUSIONS: TIPSS plus VBL without long term surveillance is effective in preventing oesophageal variceal rebleeding, and has the potential for low rates of encephalopathy. Therefore, VBL with short term TIPSS surveillance is a suitable alternative to long term TIPSS surveillance in the prevention of oesophageal variceal rebleeding.

Entities:  

Mesh:

Year:  2004        PMID: 14960530      PMCID: PMC1773959          DOI: 10.1136/gut.2003.013532

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  27 in total

1.  Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis.

Authors:  G V Papatheodoridis; J Goulis; G Leandro; D Patch; A K Burroughs
Journal:  Hepatology       Date:  1999-09       Impact factor: 17.425

2.  TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial.

Authors:  Angels Escorsell; Rafael Bañares; Juan Carlos García-Pagán; Rosa Gilabert; Eduardo Moitinho; Belén Piqueras; Concepció Bru; Antonio Echenagusia; Alicia Granados; Jaume Bosch
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

3.  The role of duplex and colour Doppler ultrasound in the follow-up evaluation of transjugular intrahepatic portosystemic stent shunt (TIPSS).

Authors:  J M Ferguson; R Jalan; D N Redhead; P C Hayes; P L Allan
Journal:  Br J Radiol       Date:  1995-06       Impact factor: 3.039

4.  Transjugular intrahepatic portosystemic shunt stenosis and revision: early and midterm results.

Authors:  Z J Haskal; M J Pentecost; M C Soulen; R D Shlansky-Goldberg; R A Baum; C Cope
Journal:  AJR Am J Roentgenol       Date:  1994-08       Impact factor: 3.959

5.  "Proving the null hypothesis" in clinical trials.

Authors:  W C Blackwelder
Journal:  Control Clin Trials       Date:  1982-12

Review 6.  Primary prophylaxis of variceal bleeding in cirrhosis.

Authors:  B T Brett; P C Hayes; R Jalan
Journal:  Eur J Gastroenterol Hepatol       Date:  2001-04       Impact factor: 2.566

7.  Incidence of shunt occlusion or stenosis following transjugular intrahepatic portosystemic shunt placement.

Authors:  C D Lind; T W Malisch; W K Chong; W O Richards; C W Pinson; S G Meranze; M Mazer
Journal:  Gastroenterology       Date:  1994-05       Impact factor: 22.682

8.  Transjugular intrahepatic portosystemic stent-shunt (TIPSS): long-term follow-up.

Authors:  R Jalan; D N Redhead; K J Simpson; R A Elton; P C Hayes
Journal:  QJM       Date:  1994-09

9.  Variceal hemorrhage: a critical evaluation of survival analysis.

Authors:  J L Smith; D Y Graham
Journal:  Gastroenterology       Date:  1982-05       Impact factor: 22.682

10.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

Authors:  R Peto; M C Pike; P Armitage; N E Breslow; D R Cox; S V Howard; N Mantel; K McPherson; J Peto; P G Smith
Journal:  Br J Cancer       Date:  1977-01       Impact factor: 7.640

View more
  5 in total

1.  Transjugular intrahepatic portosystemic stent shunt (TIPSS) modification in the management of post-TIPSS refractory hepatic encephalopathy.

Authors:  N Kochar; D Tripathi; H Ireland; D N Redhead; P C Hayes
Journal:  Gut       Date:  2006-03-29       Impact factor: 23.059

2.  Endoscopic band ligation for bleeding lesions in the small bowel.

Authors:  Takashi Ikeya; Naoki Ishii; Yuto Shimamura; Kaoru Nakano; Mai Ego; Kenji Nakamura; Koichi Takagi; Katsuyuki Fukuda; Yoshiyuki Fujita
Journal:  World J Gastrointest Endosc       Date:  2014-10-16

3.  Secondary prevention of variceal bleeding in adults with previous oesophageal variceal bleeding due to decompensated liver cirrhosis: a network meta-analysis.

Authors:  Maria Corina Plaz Torres; Lawrence Mj Best; Suzanne C Freeman; Danielle Roberts; Nicola J Cooper; Alex J Sutton; Davide Roccarina; Amine Benmassaoud; Laura Iogna Prat; Norman R Williams; Mario Csenar; Dominic Fritche; Tanjia Begum; Sivapatham Arunan; Maxine Tapp; Elisabeth Jane Milne; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2021-03-30

4.  Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage: A randomized trial.

Authors:  Ajit Agarwal; Sathasivam Suresh Kumar; Jagdish Sadasivan; Vikram Kate
Journal:  J Pharmacol Pharmacother       Date:  2015 Jan-Mar

5.  Transjugular intrahepatic portal shunt in the treatment of portal hypertension due to cirrhosis: single center experience.

Authors:  Yun Chen; Hanyu Qiu; Xiaomei Zhang
Journal:  BMC Surg       Date:  2019-12-12       Impact factor: 2.102

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.